TMDX - TransMedics Group, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
21,091
13,017
7,685
6,209
Cost of Revenue
9,470
7,283
5,548
5,443
Gross Profit
11,621
5,734
2,137
766
Operating Expenses
Research Development
17,094
13,656
14,957
15,637
Selling General and Administrative
21,797
12,315
7,606
8,115
Total Operating Expenses
38,891
25,971
22,563
23,752
Operating Income or Loss
-27,270
-20,237
-20,426
-22,986
Interest Expense
4,363
2,720
1,072
979
Total Other Income/Expenses Net
-324
-758
707
-100
Income Before Tax
-31,957
-23,715
-20,791
-24,065
Income Tax Expense
48
41
32
0
Income from Continuing Operations
-32,005
-23,756
-20,823
-24,065
Net Income
-32,005
-23,756
-20,823
-24,065
Net Income available to common shareholders
-31,460
-23,211
-20,823
-24,065
EBITDA
-
-20,226
-19,089
-22,660